The Malaria Heart Disease Study
NCT04445103 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 597
Last updated 2022-07-19
Summary
The Malaria Heart Disease Study is a prospective longitudinal cohort study of a random sample of approximately 1200 individuals from the state of Acre in Brazil. The overall hypothesis is that patients who have (i) previously suffered from a malaria infection or (ii) patients with ongoing symptomatic malaria will benefit from having an echocardiogram and blood tests performed as a screening tool to diagnose early cardiac impairment and prevent future cardiovascular disease.
Conditions
- Plasmodium Falciparum
- Plasmodium Vivax
- Heart Diseases
- Cardiovascular Diseases
Interventions
- DIAGNOSTIC_TEST
-
Assessment of cardiac function
Echocardiographic examination and assessment of cardiac biomakers
Sponsors & Collaborators
-
Federal University of Acre
collaborator UNKNOWN -
University of Sao Paulo
collaborator OTHER -
Independent Research Fund Denmark
collaborator INDUSTRY -
University Hospital, Gentofte, Copenhagen
lead OTHER
Principal Investigators
-
Philip Brainin, MD, PhD · Federal University of Acre
-
Odilson Silvestre, MD, PhD, MPH · Federal University of Acre
-
Tor Biering-Sørensen, MD, PhD, MPH · Gentofte University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-21
- Primary Completion
- 2021-01-25
- Completion
- 2021-01-25
Countries
- Brazil
Study Locations
More Related Trials
-
Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil
NCT03610399 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Induction of an Protective Immune Response to Malaria
NCT00442377 ·Status: COMPLETED ·Phase: NA
-
Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System
NCT04353245 ·Status: UNKNOWN
-
A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers
NCT01055002 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cotrifazid Safety and Efficacy Against Malaria
NCT00322907 ·Status: TERMINATED ·Phase: PHASE2
-
Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa
NCT00677833 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification Study
NCT05085301 ·Status: COMPLETED
-
Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection
NCT00761020 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)
NCT01107145 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Pharmacokinetics Study of DM1157 to Treat Malaria
NCT03490162 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability & Pharmacokinetics (PK) of Co-administered Single Doses of OZ439 and Mefloquine (MQ) in Healthy Volunteers
NCT01615822 ·Status: TERMINATED ·Phase: PHASE1
-
A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria
NCT00282919 ·Status: COMPLETED ·Phase: PHASE2
-
Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil
NCT02043652 ·Status: COMPLETED ·Phase: NA
-
Chloroquine and Post Malaria Anaemia Study
NCT00473837 ·Status: COMPLETED ·Phase: NA
-
Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria
NCT00616304 ·Status: SUSPENDED ·Phase: PHASE2
-
Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.
NCT00367653 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy
NCT00701961 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chloroquine Alone or in Combination for Malaria in Children in Malawi
NCT00379821 ·Status: COMPLETED ·Phase: PHASE3
-
Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
NCT01728701 ·Status: COMPLETED ·Phase: PHASE1
-
Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
NCT00084227 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of the ECG Effects Related to Pharmacokinetic Profile of Chloroquine and Piperaquine
NCT02192944 ·Status: COMPLETED ·Phase: PHASE4
-
Malaria In Pregnancy in Central India
NCT03955263 ·Status: UNKNOWN
-
DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil
NCT03208907 ·Status: COMPLETED ·Phase: PHASE3
-
Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa
NCT00082576 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Three Plasmodium Falciparum Isolates in a Controlled Human Malaria Infection
NCT01627951 ·Status: COMPLETED ·Phase: NA